000 | 01750nam a2200193Ia 4500 | ||
---|---|---|---|
003 | NULRC | ||
005 | 20250520103024.0 | ||
008 | 250520s9999 xx 000 0 und d | ||
020 | _a9789241209922 | ||
040 | _cNULRC | ||
050 | _aRA 8 .W67 2015 | ||
245 | 0 |
_aWHO Expert committee on specifications for pharmaceutical preparations : _bforty-ninth report. |
|
260 |
_aGeneva, Switzerland : _bWorld Health Organization, _cc2015 |
||
300 |
_axi, 210 pages ; _c24 cm. |
||
505 | _a1. Introduction -- 2. General policy -- 3. Quality control - specifications and tests -- 4. Quality control - international reference materials (International Chemical Reference Substances and Infrared Reference Spectra) -- 5. Quality control - national laboratories -- 6. Quality assurance - good manufacturing practices -- 7. Quality assurance - new initiatives -- 8. Quality assurance - distribution and trade of pharmaceuticals -- 9. Prequalification of priority essential medicines -- 10. Prequalification of active pharmaceutical ingredients -- 11. Prequalification of quality control laboratories -- 12. Regulatory guidance -- 13. Nomenclature, terminology and databases -- 14. Miscellaneous -- 15. Summary and recommendations. | ||
520 | _aThe WHO Technical Report Series makes available the findings of various international groups of experts that provide WHO with the latest scientific and technical advice on a broad range of medical and public health subjects. Members of such expert groups serve without remuneration in their personal capacities rather than as representatives of governments or other bodies; their views do not necessarily reflect the decisions or the stated policy of WHO. | ||
650 | _aDRUGS LAW AND LEGISLATION | ||
942 |
_2lcc _cBK |
||
999 |
_c21590 _d21590 |